Drugs / NN1952
last change Jun 2010 re-read 2 minutes ago

NN1952

Developed for
type 1 diabetes mellitus · type 2 diabetes mellitus
Investigated by
Novo Nordisk A/S

Trials 1 · a red edge is where a trial was stopped

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01028404 Nov 2009 → Jun 2010 type 1 diabetes mellitus, type 2 diabetes mellitus Novo Nordisk A/S Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NN1952 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01028404